Ampliphi Biosciences (APHB) SEC Filings & 10K Form

$2.53
+0.03 (+1.20%)
(As of 04/25/2024 ET)

Recent Ampliphi Biosciences SEC Filings

DateFilerForm TypeView
03/22/2024
7:00 AM
Ampliphi Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
3:20 PM
Ampliphi Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
3:15 PM
Ampliphi Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
7:00 PM
Ampliphi Biosciences (Issuer)
Birx Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:00 PM
Ampliphi Biosciences (Issuer)
Odysseas Kostas D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:01 PM
Ampliphi Biosciences (Issuer)
Haimovitz Jules (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:02 PM
Ampliphi Biosciences (Issuer)
Schlesinger Sarah J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:02 PM
Ampliphi Biosciences (Issuer)
Rychlik Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:03 PM
Ampliphi Biosciences (Issuer)
Peterson Todd C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:03 PM
Ampliphi Biosciences (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:05 PM
Ampliphi Biosciences (Issuer)
PATTI JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:35 PM
Ampliphi Biosciences (Subject)
Innoviva, Inc. (Filed by)
Form SC 13D/A
01/23/2024
3:17 PM
Ampliphi Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/26/2023
8:53 PM
Ampliphi Biosciences (Issuer)
Odysseas Kostas D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:53 PM
Ampliphi Biosciences (Issuer)
Birx Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:53 PM
Ampliphi Biosciences (Issuer)
Haimovitz Jules (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:54 PM
Ampliphi Biosciences (Issuer)
Rychlik Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:54 PM
Ampliphi Biosciences (Issuer)
PATTI JOSEPH M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:54 PM
Ampliphi Biosciences (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:55 PM
Ampliphi Biosciences (Issuer)
Peterson Todd C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
8:55 PM
Ampliphi Biosciences (Issuer)
Schlesinger Sarah J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
4:24 PM
Ampliphi Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/22/2023
6:17 PM
Ampliphi Biosciences (Issuer)
Rychlik Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2023
7:00 AM
Ampliphi Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
6:30 AM
Ampliphi Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
6:30 AM
Ampliphi Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
6:15 AM
Ampliphi Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
3:34 PM
Ampliphi Biosciences (Filer)
Form DEF 14A
08/03/2023
3:35 PM
Ampliphi Biosciences (Filer)
Form DEFA14A
08/03/2023
3:37 PM
Ampliphi Biosciences (Filer)
Form ARS
07/24/2023
3:30 PM
Ampliphi Biosciences (Filer)
Form PRE 14A
07/19/2023
3:30 PM
Ampliphi Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2023
8:56 AM
Ampliphi Biosciences (Issuer)
Birx Deborah (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2023
7:27 AM
Ampliphi Biosciences (Subject)
Innoviva, Inc. (Filed by)
Form SC 13D/A
07/11/2023
7:15 AM
Ampliphi Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
3:30 PM
Ampliphi Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
1:14 PM
Ampliphi Biosciences (Issuer)
Averill Julianne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSEAMERICAN:APHB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners